retatrutide phase 2 trial results Looking forward to when #retatrutide's 3 will become available. There are are 4 planned TRIUMPH trials investigating retatrutide's efficacy in treating obesity and its complications: #type2diabetes #cardiovascular disease Eli Lilly's New Weight-Loss Treatment

of the human body (ref.4,9,10)

Nausea occurred in 16-46% of patients depending on dose, diarrhea in 16-26%, and vomiting in 8-22%

Furthermore, TIMP-2 can induce a pro-fibrotic response (myofibroblast activation and increased collagen synthesis) in a manner potentially independent of its MMP-inhibitory activity [130] (Table 1)

These predispositions should be interpreted with a qualified healthcare provider as one factor among clinical history, comorbidities, and medication tolerability

The pharmaceutical industry has welcomed a host of therapies and vaccines into this revered club, with indications covering everything from cancer and covid-19 to arthritis and atrial fibrillation. In 1986, 10 years after it was first introduced by Smith Kline & French, sales of peptic ulcer treatment Tagamet (cimetidine) surpassed the $1 billion mark, making it the first drug in history to be classified as a blockbuster.2 Since then, the pharmaceutical industry has welcomed a host of therapies and vaccines into this revered club, with indications covering everything from cancer and covid-19 to arthritis and atrial fibrillation

Nonetheless, the net effect from the meta-analysis supports the combined therapy, although it exhibits considerable heterogeneity and includes very few studies